Anaphylaxis & Acute Allergic Reactions in the Emergency Department Theodore J. Gaeta, DO, MPH Sunday Clark, MPH Carlos A.

Download Report

Transcript Anaphylaxis & Acute Allergic Reactions in the Emergency Department Theodore J. Gaeta, DO, MPH Sunday Clark, MPH Carlos A.

Anaphylaxis & Acute Allergic Reactions in the Emergency Department

Theodore J. Gaeta, DO, MPH Sunday Clark, MPH Carlos A. Camargo, Jr., MD, DrPH On behalf of the MARC Investigators www.emnet-usa.org

Outline

Case Presentation

Prevalence and Natural History

Pathophysiology

ED Diagnosis and Management

Food-related Allergic Reactions

Post-care Plans

www.emnet-usa.org

Case Presentation

19 year old female with acute onset dyspnea

–

Dyspnea, wheezing, vomiting and generalized flushing

–

“minutes after eating a chocolate chip cookie”

–

Past medical history: eczema

www.emnet-usa.org

Case Presentation

(continued) Vital signs

–

SBP 80/p, P 124, R 40, T 98.8

o F (37.1

o C)

–

Airway patent, diminished breath sound at the bases with wheezing in the upper fields

–

Weak pulses with delayed capillary refill

–

Diffuse erythematous rash observed and Medic Alert tag indicates peanut allergy

www.emnet-usa.org

Anaphylaxis

Multi-system syndrome resulting from mediator release

Acute onset

Varies from mild and self-limited to fatal

IgE and non-IgE mediated

www.emnet-usa.org

Anaphylaxis

Incidence

–

21 per 100,000 person-years (95% confidence interval [CI]: 17 - 25 per 100,000 person-years) 1

–

10.5 per 100,000 person-years among children (95% CI: 8.1 – 13.3 per 100,000 person-years) 2 1

Yocum et al. J Allergy Clin Immunol 1999

2

Bohlke et al. J Allergy Clin Immunol 2004

www.emnet-usa.org

Estimated prevalence of Generalized Allergic Reaction*

Insect sting Food Drug RCM Allergen immuno Tx Latex All causes 3% of adults 1-3% of children 1% of adults 0.1% of cases 3% of patients 1% of adults 5% of adults

*urticaria / angioedema or dyspnea or hypotension

Anaphylaxis - Clinical Manifestations

Cardiovascular:

–

Tachycardia then hypotension

– –

Shock:

50% intravascular volume loss Bradycardia (4%) (transient or persistent)*

–

Myocardial ischemia

Lower respiratory: bronchoconstriction wheeze, cough, shortness of breath

Upper respiratory:

–

Laryngeal/pharyngeal edema

–

Rhinitis symptoms

Fisher. Anesth Intens Care 1986

www.emnet-usa.org

Anaphylaxis - Clinical Manifestations

Cutaneous: Pruritus, urticaria, angioedema, flushing

Gastrointestinal: Nausea, emesis, cramps, diarrhea

Ocular: Pruritus, tearing, redness

Genitourinary: Urinary urgency, uterine cramps

www.emnet-usa.org

Anaphylaxis -Temporal Pattern

Uniphasic

Biphasic

–

Initial allergic reaction

–

Recurrence of same manifestations up to 8 hours later

Protracted

–

Up to 32 hours

–

May not be prevented by glucocorticoids

www.emnet-usa.org

Anaphylaxis Mediators

Histamine

–

H1: smooth muscle contraction vasc permeability

–

H2: vascular permeability

–

H1+H2: vasodilatation, pruritus

 

Leukotrienes

–

Smooth muscle contraction

–

vascular permeability and dilatation Nitric Oxide

– –

Smooth muscle relaxation vascular permeability and dilatation

www.emnet-usa.org

Causes of Anaphylaxis

www.emnet-usa.org

Causes of IgE-Mediated Anaphylaxis

Antibiotics and other medications

-lactams, tetracyclines, sulfas

Foreign proteins Latex, hymenoptera venoms, heterologous sera, protamine, seminal plasma, chymopapain

Foods Shellfish, peanuts, and tree nuts

Exercise induced

www.emnet-usa.org

Causes of Anaphylactoid Mediator Release

Complement activation

– – –

Iodinated dye Aggregated IgG IgA deficiency

Unknown mechanisms

– – –

Aspirin Opiates Local anesthetics

www.emnet-usa.org

Severity of Anaphylaxis Risk Factors

Male

Consistent antigen administration

Shorter time elapsed since last reaction

Asthma

www.emnet-usa.org

Anaphylaxis Fatalities Post Mortem Findings

Airway (laryngeal) and tissue (visceral) edema

Pulmonary hyperinflation

Tissue eosinophilia

Elevated serum tryptase

Myocardial injury

www.emnet-usa.org

Anaphylaxis Fatalities

Fatalities

@

4%

Increased risk

– 

blockade, severe hypotension, bradycardia, sustained bronchospasm, poor response to epinephrine

–

Adrenal insufficiency

–

Asthma

–

Coronary artery disease

Van der Klauw et al. Clin Exp Allergy 1996

www.emnet-usa.org

Anaphylaxis Fatalities

60 50 40 30 20 10 0 0-9 10-19 Age 20-29

Bock SA et al. J Allergy Clin Immunol 2001

30+

www.emnet-usa.org

Anaphylaxis Differential Diagnosis

Vasovagal syncope

Systemic mastocytosis

Scombroid (fish) poisoning

Other causes of shock

www.emnet-usa.org

Anaphylaxis Diagnosis

Clinical features

Serum tryptase (measurable up to 6 hours)

www.emnet-usa.org

Anaphylaxis Treatment

O 2 , airway maintenance & IV fluids

Loose tourniquet? (to extremity for bee sting)

Epinephrine

–

0.01 ml/kg (1:1000) IM q 10-20 min (max 0.3-0.5 ml)

–

In shock, 0.5- 5 mcg/min (1:10,000) IV to maintain SBP

H1 + H2 histamine receptor antagonists

–

Diphenhydramine, 1 mg/kg PO/ IM/ IV (max 75 mg)

–

Ranitidine

•

Adult, 4 mg/kg PO (max 300 mg), 50 mg IM/IV q 6 h

•

Child, 1.5 mg/kg IM/IV (max 50 mg)

www.emnet-usa.org

Treatment

(continued)

Corticosteroids

–

1-2 mg/kg prednisone PO (max 75 mg)

–

2 mg/kg methylpredisolone IV (max 250 mg)

•

Not effective in protracted anaphylaxis

•

Effective in iodinated dye prophylaxis

Inhaled beta-agonists Albuterol 2.5 mg q 15-20 min

Glucagon (consider if patient is on

-blocker)

www.emnet-usa.org

Return to case

Placed on supplemental O 2 monitor and cardiac

–

IV access and fluid bolus

–

Albuterol via nebulizer

–

Epinephrine: 0.3 ml IM

–

Diphenhydramine: 50 mg IV

–

Ranitidine: 50 mg IV

–

Methylpredisolone: 125 mg IV

www.emnet-usa.org

Response

Despite multiple doses of epinephrine and albuterol the patient remained in respiratory distress

Impending respiratory failure: Rapid sequence intubation

Transferred to ICU

Further history: The patient’s roommate presents a Medic Alert tag indicating peanut allergy

www.emnet-usa.org

Food-Related Allergic Reaction

Epidemiology

Fatal

Peanut

Schools

Exercise

www.emnet-usa.org

Fatal Food Anaphylaxis

     

Frequency (USA): ~ 150 deaths / year Risk:

– – – –

Underlying asthma Delayed epinephrine Symptom denial Previous severe reaction History: known allergic food Key foods: peanut / tree nuts / shellfish Biphasic reaction Lack of cutaneous symptoms

www.emnet-usa.org

Prevalence of Food Allergy

Perception by public: 20-25%

Confirmed allergy (oral challenge)

– –

Adults: 1-2% Infants/Children: 6-8%

Dye / preservative allergy (rare)

Specific Allergens

– – –

Dependent upon societal eating pattern Milk (infants): 2.5% Peanut / tree nuts in general population: 1.1%

www.emnet-usa.org

Diagnosis: History / Physical

History: symptoms, timing, reproducibility

Acute reactions vs. chronic disease

Diet details / symptom diary

–

Specific causal food(s)

–

“Hidden” ingredient(s)

Physical examination: evaluate disease severity

Identify general mechanism

– –

Allergy vs. intolerance IgE vs. non-IgE mediated

www.emnet-usa.org

Disposition

Most patients with allergic reactions can be discharged

Hospitalize or observe patients with airway angioedema, persistent brochospasm, hypoperfusion, cardiac problems, on

-blockers

Observe 4 to 6 hours

www.emnet-usa.org

Risk Management for Anaphylaxis

Education

– – –

Allergen avoidance Written emergency action plan Resources (eg, FAAN website: www.foodallergy.org

)

Prescription for self-injectable epinephrine

Referral to an allergy specialist

Anaphylaxis – Operational Definition

Two or more organ systems

– – –

skin (e.g., hives) respiratory (e.g., swelling of the lips, tongue, or throat; trouble breathing or shortness of breath; stridor, wheezing)

–

cardiovascular (e.g., hypotension, dizziness or fainting, altered mental status) gastrointestinal (e.g., trouble swallowing, abdominal pain)

Hypotension (SBP <100 mmHg)

www.emnet-usa.org

“State of the ED” Objective

To describe ED management of food allergy

Methods

The Multicetner Airway Research Collaboration is a program within the Emergency Medicine Network (www.emnet-usa.org)

Clark et al. J Allergy Clin Immunol 2004

www.emnet-usa.org

9/22/04

EMNet Sites

(137 US sites)

www.emnet-usa.org

Methods

(continued)

21 North American EDs participated in this study

Chart review of randomly selected patients presenting to the ED over a one year period with physician-diagnosed food allergy

ICD-9 codes

–

693.1 (dermatitis due to food)

– – –

995.0 (other anaphylactic shock) 995.3 (allergy, unspecified) 995.60 (allergy due to unspecified food)

–

995.61-995.69 (allergy due to specified foods)

www.emnet-usa.org

Results

678 patients with physician-identified food allergy were randomly selected for chart review

–

57% female, 43% white

–

Mean age, 29 ± 18 years

92% had documentation of a specific food item as the cause of the current reaction

Only 41% of patients had documentation of a history of allergic reaction to the specific food that caused the current reaction

www.emnet-usa.org

Specific Foods

*

Crustaceans Peanut Fruits and vegetables Fish Tree nuts Milk Eggs Additives Other foods

Percentage

19 12 12 10 9 6 2 1 36

95% CI

16 – 22 9 – 14 10 – 15 8 – 12 7 – 11 4 – 8 1 – 4 0.5 – 2 33 – 40

* More than one option allowed.

www.emnet-usa.org

Presentation and ED Course

Arrived by ambulance (%) Duration of symptoms  1 hour (%) n=678 18 37 Received antihistamines in ED (%) Received systemic steroids in ED (%) Received epinephrine in ED (%) Respiratory treatments in ED* (%) Discharged to home (%) 72 48 16 33 97 95% CI 16 – 22 33 – 41 68 – 75 45 – 52 13 – 19 29 – 37 95 – 98

* Inhaled

-agonists and inhaled anticholinergics

www.emnet-usa.org

Outcomes

Given discharge instructions to avoid offending allergen (%) Given prescription for self-injectable epinephrine at ED or hospital discharge (%) Referred to an allergist at ED or hospital discharge (%) n=642 40 16 12 95% CI 36 – 43 14 - 20 9 - 15 www.emnet-usa.org

Instructions to Avoid Offending Allergen

100 90 30 20 10 0 80 70 60 50 40 Goal = 100% M O R Q I Overall: 40% (95% CI, 36-43%) S J L P H Site C E A N B K F T G D www.emnet-usa.org

Self-injectable Epinephrine at Discharge

100 90 80 70 60 50 40 30 20 10 0 B Goal = 100% F N Q D I E K Overall: 16% (95% CI, 14-20%) P G Site L R C T S H U J M O www.emnet-usa.org

100

Referred to Allergist at Discharge

90 80 30 20 10 0 70 60 50 40 Goal = 100% Overall: 12% (95% CI, 9-15%) H K Q R E P B D I L Site S C G M N J A T F O www.emnet-usa.org

Summary

Although allergic reactions to food can be life threatening, 18% of patients came to the ED by ambulance and only 3% were admitted

A variety of foods provoked the allergic reaction, with crustaceans and peanuts being the most common triggers

Only 16% of patients received a prescription for self-injectable epinephrine when leaving the ED

www.emnet-usa.org

Summary

(continued)

Similarly, only 12% were referred to an allergist as part of discharge instructions

At a minimum, there is poor documentation of medications prescribed at ED discharge

Although guidelines suggest specific approaches for the emergency management of food allergy, concordance to these guidelines appears low

www.emnet-usa.org

Take Home

Keys to successful management

–

Prompt recognition of the signs and symptoms of anaphylaxis

–

Early administration of IM epinephrine

–

Volume resuscitation

–

Comfort and familiarity with 2 nd therapies line

www.emnet-usa.org

Take Home

(continued) A successful post-care plan must include

–

Education

•

Allergen avoidance

• •

Written emergency action plan Educational resources (eg, www.foodallergy.org)

–

Prescription for self-injectable epinephrine

–

Referral to an allergy specialist

www.emnet-usa.org